Second-line drugs used in recent-onset rheumatoid arthritis in Brittany (France)

Joint Bone Spine

Volumn 69, Issue 1, 2002, Pages 37-42

  Saraux, Alain ^a   Berthelot, Jean Marie ^b   Chalès, Gérard ^c   Le Henaff, Catherine ^d   Thorel, Jean ^d   Hoang, Sylvie ^d   Martin, Antoine ^d   Allain, Jérôme ^a   Nouy Trolle, Isabelle ^d   Devauchelle, Valérie ^a   Youinou, Pierre ^a   Le Goff, Paul ^a  

^a SERVICE DE RHUMATOLOGIE   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c RENNES UNIVERSITY HOSPITAL   (France)

^d Rheumatology Department   (France)

Author keywords

Brittany; Rheumatoid arthritis; Second line drugs

Indexed keywords

ANTIRHEUMATIC AGENT; GLUCOCORTICOID; GOLD; HYDROXYCHLOROQUINE; METHOTREXATE; PENICILLAMINE; SALAZOSULFAPYRIDINE; TIOPRONIN;

ADULT; AGED; ANAMNESIS; ARTICLE; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; DRUG CHOICE; DRUG PREFERENCE; FEMALE; FOLLOW UP; FRANCE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PHYSICAL EXAMINATION; PRESCRIPTION; RHEUMATOID ARTHRITIS;

EID: 0036161022     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1297-319X(01)00339-6     Document Type: Article

References (20)

1. Early referral, diagnosis, and treatment of rheumatoid arthritis: Evidence for changing medical practice
2. Early treatment in rheumatoid arthritis: Rationale, evidence and implications
3. The changing face of rheumatoid arthritis therapy: Results of serial surveys
4. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
5. Ability of the ACR 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later
6. Comment le rhumatologue français traite-t-il en pratique la PR au début
7. Enquête épidémiologique nationale transversale sur la PR en milieu libéral
8. Aggressive treatment in early rheumatoid arthritis: A randomized trial
9. Evaluation of treatment of RA: One year outcomes of plaquenil (HCQ) monotherapy versus methotrexate monotherapy
10. A 36 month comparative trial of methotrexate and gold sodium thiomalate in the treatment of early active and erosive rheumatoid arthritis
11. Progression in early RA: 12 Month results from a randomized controlled trial comparing methotrexate and gold sodium thiomalate
12. Progression of joint damage in early active severe rheumatoid arthritis during 18 months of treatment: Comparison of low-dose cyclosporin and parenteral gold
13. Combination of sulfasalazine and methotrexate versus the single components in early rheumatoid arthritis: A randomized, controlled, double blind study, 52 week clinical trial
14. Combination therapy in early rheumatoid arthritis: A randomized, controlled, double blind study, 52 week clinical trial of sulfasalazine and methotrexate compared with the single components
15. Combination therapy in recent-onset rheumatoid arthritis: A randomized, double blind trial of the addition of low dose cyclosporine to patients treated with low dose chloroquine
16. Randomised comparison of combined step down prednisolone, methotrexate and sulfasalazine with sulfasalazine alone in early rheumatoid arthritis
17. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: A randomised trial
18. Treatment of poor prognosis early RA: Conventional therapy with sulfasalazine versus aggressive therapy with methotrexate, cyclosporine A and intraarticular steroïds
19. Treatment of poor-prognosis early rheumatoid arthritis